Pseudo-Meigs' syndrome;Pseudo-Meigs' syndrom

Tidsskrift for den Norske Laegeforening

Volumn 120, Issue 3, 2000, Pages 364-366

  Wiatrowska, Beata ^a   Krajci, Peter ^a   Berner, Aasmund ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CYSTADENOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOLOGY; OVARY; OVARY CARCINOMA; OVARY TUMOR; PATHOLOGY; PLEURA EFFUSION;

ADULT; CYSTADENOMA, MUCINOUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MEIGS SYNDROME; OVARIAN NEOPLASMS; OVARY; PLEURAL EFFUSION, MALIGNANT;

EID: 0034731699     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Young R, Perz CA, Hoskins WJ. Cancer of the ovary. I: De Vita jr., Hellman S, Rosenberg SA, red. Principles and practice of oncology. Philadelphia: Lippincott, 1993: 1226-63.
2. Meigs JV, Cass JW. Fibroma of the ovary with ascites and hydrothorax with a report of seven cases. Am J Obstet Gynecol 1937; 33: 249-66.
3. Meigs JV. Fibroma of the ovary with ascites and hydrothorax - Meigs' syndrome. Am J Obstet Gynecol 1954; 67: 962-87.
4. Carson SA, Mazur MT. Atypical endometroid cystadenofibroma with Meigs' syndrome. Ultrastructure and S-phase fraction. Cancer 1982; 49: 472-9.
5. Pratt-Thomas HR, Kreutner A, Underwood PB, Dowdeswell RH. Proliferative and malignant Brenner tumors of ovary. Report of two cases, one with Meigs' syndrome, review of literature, and ultrastructural comparisons. Gynecol Oncol 1976; 4: 176-93.
6. Bridgewater JA, Rustin GJS. Pseudo-Meigs' syndrome secondary to an ovarian germ cell tumor. Gynecol Oncol 1997; 66: 535-41.
7. Dunn JS, Anderson CD, Method MW, Brost BC. Hydrop degenerating leiomyoma presenting as pseudo-Meigs' syndrome with elevated CA 125. Obstet Gynecol 1998; 92: 648-9.
8. Kazanov L, Ander DS, Enriquez E, Jaggi FM. Pseudo-Meigs' syndrome. Am J Emerg Med 1998; 16: 404-5.
9. Timmerman D, Moerman P, Vergote I. Meigs' syndrome with elevated serum CA 125 levels: two case reports and review of the literature. Gynecol Oncol 1995; 59: 405-8.
10. Davidson B, Risberg B, Kristensen G, Kvalheim G, Emilsen E, Bjåmer A et al. Detection of cancer cells in effusions from pat ents diagnosed with gynecological malignancies - evaluation of five epithelial markers. Virchoffs Arch 1999; 435: 43-9.
11. Nagel H, Hemmerlein B, Ruschenburg I, Huppe K, Droese M. The value of anti-calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology. Pathol Res Pract 1998; 194: 759-64.
12. Ordonez NG. The immunohistochemical diagnosis of epithelial mesothelioma. Hum Pathol 1999; 30: 313-23.
13. Simsir A, Fetsch P, Mehta D, Zakowski M, Abati A. E-cadherin, N-cadherin, and calretinin in pleural effusions: the good, the bad, the worthless. Diagn Cytopathol 1999; 20: 125-30.